Income StatementBalance SheetCash FlowSegments
STERIS logo

STERIS Cash Flow Statement

Operating, investing, and financing cash movements

STERIS generated $1.3B in operating cash flow over the trailing twelve months. After $369.0M in capital expenditures, free cash flow was $972.4M. Free cash flow increased 0.2% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$1.3BNet Cash From Investing (TTM)-$512.5MNet Cash From Financing (TTM)-$568.2MCapital Expenditures (TTM)$369.0MDepreciation And Amortization Cf (TTM)$486.5MNet Change In Cash (TTM)$267.9M
Latest FilingQ1 2026
Report Date2026-05-29
Market Cap$20.9B
P/E Ratio26.67
ROE11.35%

Operating

MetricQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Other non-cash income (expense)$7.8M—-$14.5M——$17.8M
Gain on sale of property, plant, and equipment-$300.0K-$2.7M$0.0-$100.0K-$3.2M-$300.0K
Other non-cash income (expense)$7.8M—-$14.5M——$17.8M
Change in accounts payable—$41.1M$9.8M$13.2M-$28.8M$56.9M
Change in accounts receivable—$108.1M-$119.2M——$123.5M
Change in accrued liabilities$30.8M$43.4M-$9.2M-$42.9M$25.6M$74.3M
Change in inventories—-$73.8M$42.5M$18.2M$1.8M—
Change in other assets$27.0M$31.9M-$18.9M-$6.6M$15.5M$32.7M
Other working capital changes$7.8M—-$14.5M——$17.8M
Deferred income taxes-$1.7M-$52.7M$0.0-$100.0K-$100.0K-$16.7M
Depreciation and amortization$125.9M$122.3M$119.4M$121.7M$122.0M$123.4M
Gain (loss) on sale of assets-$300.0K-$2.7M$0.0-$100.0K-$3.2M-$300.0K
Other Non-Cash Income (Expense)$7.8M—-$14.5M——$17.8M
Other Non-cash Income (Expense)$7.8M—-$14.5M——$17.8M
Other Non-cash Income (Expense)$7.8M—-$14.5M——$17.8M
Net cash from operating activities$332.8M$260.8M$420.0M$287.8M$298.2M$335.4M
Net income$173.3M$146.1M$178.0M$192.5M$194.3M$220.3M
Other non-cash income (expense)$7.8M—-$14.5M——$17.8M
Gain (Loss) on Disposition of Business And Equity Investments, Net—-$10.9M$0.0-$300.0K$0.0$600.0K
Increase (Decrease) in Prepaid Expense and Other Assets$27.0M$31.9M-$18.9M-$6.6M$15.5M$32.7M
Loss on classification as held for sale$0.0$0.0$0.0$0.0$0.0$0.0
Other Noncash Income (Expense)$7.8M—-$14.5M——$17.8M
Other Non-cash Income and Expense$7.8M—-$14.5M——$17.8M
Other Non-Cash Adjustments$7.8M—-$14.5M——$17.8M
Other Non-Cash Income and Expense$7.8M—-$14.5M——$17.8M
Stock-based compensation$15.3M$9.8M$11.9M$21.2M$15.7M$12.9M

Investing

MetricQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Acquisitions, net of cash acquired$36.2M$400.0K$15.0M—$5.1M—
Proceeds from sale of other investments$0.0$0.0$0.0$0.0$0.0$0.0
Capital expenditures$89.2M$70.9M$93.6M$86.5M$98.7M$90.2M
Proceeds from Sale of Other Investments$0.0$0.0$0.0$0.0$0.0$0.0
Divestiture of businesses, net of cash transferred$1.5M—$0.0$0.0$0.0—
Proceeds from disposals of property, plant and equipment$0.0$9.2M$100.0K——$100.0K
Proceeds from other investments$0.0$0.0$0.0$0.0$0.0$0.0
Net cash from investing activities——-$108.5M-$88.3M-$98.5M-$217.2M
Proceeds from maturities/sales of investments$0.0$0.0$0.0$0.0$0.0$0.0
Proceeds from sale of businesses$1.5M$3.2M$0.0$0.0$0.0$0.0
Proceeds from sale of property, plant and equipment$0.0$9.2M$100.0K——$100.0K
Purchases of investments$0.0$10.8M——$5.0M$127.2M
Proceeds from Sale of Other Investments$0.0$0.0$0.0$0.0$0.0$0.0
Proceeds from divestiture of prepaid business$1.5M—$0.0$0.0$0.0—

Financing

MetricQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Proceeds from lines of credit$0.0-$127.3M-$30.5M-$4.3M$0.0$37.8M
Proceeds from minority shareholders——$0.0$0.0$0.0$0.0
Contributions from noncontrolling interests——$0.0$0.0$0.0$0.0
Repayments of debt$80.0M—$125.0M———
Distributions to noncontrolling interests—$500.0K$350.0K$350.0K$350.0K$350.0K
Dividends paid$56.2M$56.0M$56.2M$61.9M$61.9M$61.8M
Payments to Noncontrolling Interests—$500.0K$350.0K$350.0K$350.0K$350.0K
Other, net$300.0K$6.1M$9.3M$7.6M$15.4M$600.0K
Repayments of Senior Debt$80.0M—$125.0M———
Repayments of Term Loans$159.5M$159.5M$0.0$0.0$0.0$0.0
Repayments of Secured Debt——$0.0$0.0$0.0—
Net proceeds from sales of subsidiary shares——$0.0$0.0$0.0$0.0
Payment of Deferred Purchase Consideration$300.0K$6.1M$9.3M$7.6M$15.4M$600.0K
Noncontrolling interest transactions and other$300.0K$6.1M$9.3M$7.6M$15.4M$600.0K
Proceeds from Minority Shareholders——$0.0$0.0$0.0$0.0
Proceeds from Sale of Noncontrolling Interests——$0.0$0.0$0.0$0.0
Net cash from financing activities-$214.4M-$178.1M-$213.1M-$159.2M-$98.0M-$97.9M
Other financing activities$300.0K$6.1M$9.3M$7.6M$15.4M$600.0K
Payment of debt issuance costs$575.0K$575.0K———$0.0
Noncontrolling Interests Activity and Other$300.0K$6.1M$9.3M$7.6M$15.4M$600.0K
Proceeds from Minority Shareholders——$0.0$0.0$0.0$0.0
Repurchases of common stock$100.5M$200.0K$10.6M$100.5M$50.1M$74.3M
Proceeds from Minority Shareholders——$0.0$0.0$0.0$0.0
Payments of consent fees related to long-term debt$575.0K$575.0K———$0.0

Free Cash Flow

MetricQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Free cash flow$243.6M$189.9M$326.4M$201.3M$199.5M$245.2M

Other

MetricQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Effect of exchange rate changes on cash-$11.5M$3.6M$9.6M—$2.9M—
Net increase (decrease) in cash-$17.0M—$108.0M$39.5M$104.5M$15.9M
Payments Of Merger Related Costs Financing Activities$100.0K$100.0K$100.0K$100.0K$100.0K$100.0K